Risk scores generated by a deep learning algorithm (Mirai) can identify women at higher risk for developing interval breast ...

New findings demonstrating a reversal in acute vaso-occlusive pain in sickle cell disease by a novel transdermal curcumin gel formulation to be presented* at the 67th Annual American Society of ...

“We look forward to sharing additional data from our clinical program and continuing to advance novel therapies that may improve outcomes for patients with difficult-to-treat cancers.” In addition, an ...

Amgen to present new data from cardiovascular portfolio, including late-breaking results from phase 3 VESALIUS-CV trial of Repatha at AHA scientific sessions: Thousand Oaks, Calif ...

Abstract 302 - Oral presentation Title ... Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies ...

Through Dr Survé Philanthropies and several educational foundations, he has empowered thousands of young South Africans to ...

Additionally, the more than 50 abstracts accepted at ASH include new and updated data from Incyte’s MPN, GVHD and hematology ...

Crushing bones to blend paint is intense, as is scaling abstract paintings up to the size of buildings, but that’s normal work for artist Ellen Picken. The MAC Gallery exhibits ...

Genmab A/S today announced that more than 20 abstracts evaluating epcoritamab-bysp, a T-cell engaging bispecific antibody administered subcutaneously, across lines of therapy and B-cell non-Hodgkin's ...

The activation and deactivation of apoptosis is a promising field of research in basic biomedical research. The team led by Prof. Franz Hagn from the Chair of Structural Membrane Biochemistry at the ...